SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America
New partnership combines Shilpa Biologicals' development and manufacturing capabilities with SteinCares' regional commercialization platformCollaboration aims to expand patient access to cost-effective treatments and reinforces SteinCares' leadership in biosimilars across Latin...
Read more





